(Q45929973)

English

Mobilization of peripheral blood stem cells for autologous transplant in non-Hodgkin's lymphoma and multiple myeloma patients by plerixafor and G-CSF and detection of tumor cell mobilization by PCR in multiple myeloma patients.

scientific article published on 13 July 2009

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/19597422

Mobilization of peripheral blood stem cells for autologous transplant in non-Hodgkin's lymphoma and multiple myeloma patients by plerixafor and G-CSF and detection of tumor cell mobilization by PCR in multiple myeloma patients. (English)

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/19597422

multiple myeloma

1 reference

based on heuristic

inferred from title

Gerhard Ehninger

2

object named as

G Ehninger

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/19597422

Gary B. Calandra

10

object named as

G Calandra

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/19597422

9

object named as

K Badel

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/19597422

author name string

S Fruehauf

1

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/19597422

K Hübel

3

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/19597422

J Topaly

4

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/19597422

H Goldschmidt

5

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/19597422

A D Ho

6

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/19597422

S Müller

7

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/19597422

M Moos

8

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/19597422

language of work or name

0 references

publication date

13 July 2009

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/19597422

Bone Marrow Transplantation

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/19597422

45

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/19597422

2

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/19597422

269-275

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/19597422

https://scigraph.springernature.com/pub.10.1038/bmt.2009.142

0 references

New strategies for mobilization of hematopoietic stem cells

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.142

21 January 2018

It's moving day: factors affecting peripheral blood stem cell mobilization and strategies for improvement [corrected].

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.142

21 January 2018

Rapid mobilization of murine and human hematopoietic stem and progenitor cells with AMD3100, a CXCR4 antagonist

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.142

21 January 2018

The CXCR4 antagonist AMD3100 releases a subset of G-CSF-primed peripheral blood progenitor cells with specific gene expression characteristics.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.142

21 January 2018

The use of AMD3100 plus G-CSF for autologous hematopoietic progenitor cell mobilization is superior to G-CSF alone

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.142

21 January 2018

What is the optimum number of CD34+ peripheral blood stem cells for an autologous transplant?

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.142

21 January 2018

AMD3100 plus G-CSF can successfully mobilize CD34+ cells from non-Hodgkin's lymphoma, Hodgkin's disease and multiple myeloma patients previously failing mobilization with chemotherapy and/or cytokine treatment: compassionate use data

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.142

21 January 2018

Detection, clinical relevance and specific biological properties of disseminating tumour cells

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.142

21 January 2018

Inhibition of TGF-beta with neutralizing antibodies prevents radiation-induced acceleration of metastatic cancer progression.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.142

21 January 2018

Outcomes of autologous stem cell transplantation in patients with multiple myeloma who received dexamethasone-based nonmyelosuppressive induction therapy

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.142

21 January 2018

Contamination of autologous peripheral blood progenitor cell grafts predicts overall survival after high-dose chemotherapy in multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.142

21 January 2018

Monoclonal plasma cells in the blood stem cell harvest from patients with multiple myeloma are associated with shortened relapse-free survival after transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.142

21 January 2018

Infused CD34 cell dose, but not tumour cell content of peripheral blood progenitor cell grafts, predicts clinical outcome in patients with diffuse large B-cell lymphoma and follicular lymphoma grade 3 treated with high-dose therapy

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.142

21 January 2018

Relapse risk after autologous transplantation in patients with newly diagnosed myeloma is not related with infused tumor cell load and the outcome is not improved by CD34+ cell selection: long term follow-up of an EBMT phase III randomized study.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.142

21 January 2018

Efficient mobilization of peripheral blood stem cells following CAD chemotherapy and a single dose of pegylated G-CSF in patients with multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.142

7 January 2021

based on heuristic

inferred from DOI database lookup

Augmented mobilization and collection of CD34+ hematopoietic cells from normal human volunteers stimulated with granulocyte-colony-stimulating factor by single-dose administration of AMD3100, a CXCR4 antagonist

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.142

7 January 2021

based on heuristic

inferred from DOI database lookup

A quantitative PCR assay for the detection of low amounts of malignant cells in multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.142

7 January 2021

based on heuristic

inferred from DOI database lookup

Successful PBSC mobilization with high-dose G-CSF for patients failing a first round of mobilization

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.142

7 January 2021

based on heuristic

inferred from DOI database lookup

G-CSF after peripheral blood stem cell transplantation in lymphoma patients significantly accelerated neutrophil recovery and shortened time in hospital: results of a randomized BNLI trial

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.142

7 January 2021

based on heuristic

inferred from DOI database lookup

Low-dose filgrastim significantly enhances neutrophil recovery following autologous peripheral-blood stem-cell transplantation in patients with lymphoproliferative disorders: evidence for clinical and economic benefit

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.142

7 January 2021

based on heuristic

inferred from DOI database lookup

Sequential high-dose therapy with peripheral-blood progenitor-cell support in low-grade non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.142

7 January 2021

based on heuristic

inferred from DOI database lookup

Contaminating tumour cells in autologous PBSC grafts do not influence survival or relapse following transplant for multiple myeloma or B-cell non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.142

7 January 2021

based on heuristic

inferred from DOI database lookup

Purging of autologous peripheral-blood stem cells using CD34 selection does not improve overall or progression-free survival after high-dose chemotherapy for multiple myeloma: results of a multicenter randomized controlled trial

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.142

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/BMT.2009.142

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/19597422

Dimensions Publication ID

0 references

release_4ewtig6hyvghzebchwmqq35ira

1 reference

https://api.fatcat.wiki/v0/release/4ewtig6hyvghzebchwmqq35ira

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/19597422

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45929973&oldid=1842322651"